Corporate Blog

LabCorp Expands Drug Development Solutions with Acquisition of Sciformix

Sciformix extends Covance’s pharmacovigilance capabilities for post-approval safety solutions BURLINGTON, N.C.–(BUSINESS WIRE)–Jun. 11, 2018– LabCorp® (NYSE: LH), a leading global life sciences company, announced today that it has acquired Sciformix Corporation, a scientific process outsourcing company focused on pharmacovigilance and regulatory solutions...